From: Turkish adaptation and validation of the ethical decision-making competence scale
Items | Subdimension | |
---|---|---|
1. | I can analyze the barriers to decision-making faced by patients and their families. | 0.706 |
2. | I can identify the barriers to decision-making faced by patients and their families. | 0.755 |
3. | I can identify the potential risks and benefits of ethical dilemmas. | 0.772 |
4. | I can identify ethical issues related to the care of complex patients. | 0.796 |
5. | I can detect the conflict between patients and their families in their decision-making choices. | 0.656 |
6. | I can listen to the decision-making issues faced by patients and their families. | 0.727 |
7. | I can encourage patients and their families to speak out about the decision-making issues they face. | 0.678 |
8. | I am able to maintain harmonious relationships with patients and families when decision-making dilemmas are in conflict. | 0.608 |
9. | I understand the decision-making dilemmas and conflicts of patients and their families. | 0.434 |
10. | I understand and guide patients and their families through the feelings of decision-making dilemmas. | 0.444 |
11. | I can nurture and guide others to develop ethical practices in my work. | 0.787 |
12. | I am able to participate inpreventive ethics initiatives to address ethical situations in my own area practice. | 0.666 |
13. | I can describe my ethical care experience based on my professional knowledge. | 0.686 |
14. | I am able to plan the choice of ethical priorities clinical practice. | 0.563 |
15. | I can use clear and understandable words (or language) to discuss with patients and their families the choice of care best for them. | 0.666 |
16. | I can use clear and understandable words (or language) to discuss health care options with patients and their families. | 0.796 |
17. | I am able to apply ethical principles in a timely manner to inform care decisions for patients and their families. | 0.816 |
18. | I am able to grasp ethical principles and provide references for patients and their families. | 0.796 |
Total explained variance | 71.247 | |
KMO coefficient | 0.923 | |
Barlett’s test of sphericity | 3033.685; <0.001 |